151 related articles for article (PubMed ID: 31797710)
1. Impact of pretreatment with carnitine and tadalafil on contrast-induced nephropathy in CKD patients.
Armaly Z; Artol S; Jabbour AR; Saffouri A; Habashi N; Abd Elkadir A; Ghattas N; Farah R; Kinaneh S; Nseir W
Ren Fail; 2019 Nov; 41(1):976-986. PubMed ID: 31797710
[No Abstract] [Full Text] [Related]
2. Effects of phosphodiesterase-5 inhibitor on ischemic kidney injury during nephron sparing surgery: quantitative assessment by NGAL and KIM-1.
Lahoud Y; Hussein O; Shalabi A; Nativ O; Awad H; Khamaisi M; Matar I; Nativ O; Abassi Z
World J Urol; 2015 Dec; 33(12):2053-62. PubMed ID: 25981401
[TBL] [Abstract][Full Text] [Related]
3. Phosphodiesterase-5 inhibitors ameliorate structural kidney damage in a rat model of contrast-induced nephropathy.
Iordache AM; Buga AM; Albulescu D; Vasile RC; Mitrut R; Georgiadis G; Zisis IE; Mamoulakis C; Tsatsakis A; Docea AO; Calina D
Food Chem Toxicol; 2020 Sep; 143():111535. PubMed ID: 32622850
[TBL] [Abstract][Full Text] [Related]
4. [Predict value of monitoring changes of urinary neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 after coronary angiography and percutaneous coronary intervention on early diagnosis of contrast-induced nephropathy].
Wang L; Pu X
Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Apr; 42(4):301-4. PubMed ID: 24924456
[TBL] [Abstract][Full Text] [Related]
5. Effects of carnitine on oxidative stress response to intravenous iron administration to patients with CKD: impact of haptoglobin phenotype.
Armaly Z; Abd El Qader A; Jabbour A; Hassan K; Ramadan R; Bowirrat A; Bisharat B
BMC Nephrol; 2015 Aug; 16():135. PubMed ID: 26268514
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil gelatinase-associated lipocalin as an early marker of contrast-induced nephropathy after coronary angiography.
Alharazy SM; Kong N; Saidin R; Gafor AH; Maskon O; Mohd M; Zakaria SZ
Angiology; 2014 Mar; 65(3):216-23. PubMed ID: 23378196
[TBL] [Abstract][Full Text] [Related]
7. The phosphodiesterase 5 inhibitor tadalafil has renoprotective effects in a rat model of chronic kidney disease.
Tomita N; Hotta Y; Naiki-Ito A; Hirano K; Kataoka T; Maeda Y; Takahashi S; Kimura K
Physiol Rep; 2020 Sep; 8(17):e14556. PubMed ID: 32889777
[TBL] [Abstract][Full Text] [Related]
8. Sildenafil and tadalafil reduce the risk of contrast-induced nephropathy by modulating the oxidant/antioxidant balance in a murine model.
Iordache AM; Docea AO; Buga AM; Zlatian O; Ciurea ME; Rogoveanu OC; Burada F; Sosoi S; Mitrut R; Mamoulakis C; Albulescu D; Vasile RC; Tsatsakis A; Calina D
Food Chem Toxicol; 2020 Jan; 135():111038. PubMed ID: 31825855
[TBL] [Abstract][Full Text] [Related]
9. Can neutrophil gelatinase-associated lipocalin help depict early contrast material-induced nephropathy?
Lacquaniti A; Buemi F; Lupica R; Giardina C; Murè G; Arena A; Visalli C; Baldari S; Aloisi C; Buemi M
Radiology; 2013 Apr; 267(1):86-93. PubMed ID: 23297321
[TBL] [Abstract][Full Text] [Related]
10. Subclinical and clinical contrast-induced acute kidney injury: data from a novel blood marker for determining the risk of developing contrast-induced nephropathy (ENCINO), a prospective study.
Akrawinthawong K; Ricci J; Cannon L; Dixon S; Kupfer K; Stivers D; Alexander P; David S; McCullough PA
Ren Fail; 2015 Mar; 37(2):187-91. PubMed ID: 25519207
[TBL] [Abstract][Full Text] [Related]
11. Serum neutrophil gelatinase-associated lipocalin and cystatin C are early biomarkers of contrast-induced nephropathy after coronary angiography in patients with chronic kidney disease.
Alharazy SM; Kong N; Saidin R; Gafor AH; Maskon O; Mohd M; Zakaria SZ
Angiology; 2014 May; 65(5):436-42. PubMed ID: 23580616
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil gelatinase-associated lipocalin (NGAL): a promising biomarker of contrast-induced nephropathy after computed tomography.
Filiopoulos V; Biblaki D; Vlassopoulos D
Ren Fail; 2014 Jul; 36(6):979-86. PubMed ID: 24673459
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil Gelatinase-Associated Lipocalin and Contrast-Induced Acute Kidney Injury.
Quintavalle C; Anselmi CV; De Micco F; Roscigno G; Visconti G; Golia B; Focaccio A; Ricciardelli B; Perna E; Papa L; Donnarumma E; Condorelli G; Briguori C
Circ Cardiovasc Interv; 2015 Sep; 8(9):e002673. PubMed ID: 26333343
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a Diagnostic Test of Serum Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Urine KIM-1 in Contrast-Induced Nephropathy (CIN).
Liao B; Nian W; Xi A; Zheng M
Med Sci Monit; 2019 Jan; 25():565-570. PubMed ID: 30659575
[TBL] [Abstract][Full Text] [Related]
15. Phosphodiesterase-5 inhibition attenuates early renal ischemia-reperfusion-induced acute kidney injury: assessment by quantitative measurement of urinary NGAL and KIM-1.
Sohotnik R; Nativ O; Abbasi A; Awad H; Frajewicki V; Bishara B; Sukhotnik I; Armaly Z; Aronson D; Heyman SN; Nativ O; Abassi Z
Am J Physiol Renal Physiol; 2013 Apr; 304(8):F1099-104. PubMed ID: 23364806
[TBL] [Abstract][Full Text] [Related]
16. Nephroprotective potential of carnitine against glycerol and contrast-induced kidney injury in rats through modulation of oxidative stress, proinflammatory cytokines, and apoptosis.
Kunak CS; Ugan RA; Cadirci E; Karakus E; Polat B; Un H; Halici Z; Saritemur M; Atmaca HT; Karaman A
Br J Radiol; 2016; 89(1058):20140724. PubMed ID: 26562095
[TBL] [Abstract][Full Text] [Related]
17. Serum NGAL, cystatin C and urinary NAG measurements for early diagnosis of contrast-induced nephropathy in children.
Benzer M; Alpay H; Baykan Ö; Erdem A; Demir IH
Ren Fail; 2016; 38(1):27-34. PubMed ID: 26584598
[TBL] [Abstract][Full Text] [Related]
18. Implications of the changes in serum neutrophil gelatinase-associated lipocalin and cystatin C in patients with chronic kidney disease.
Shen SJ; Hu ZX; Li QH; Wang SM; Song CJ; Wu DD; He JL; Guan JC; Shan JP
Nephrology (Carlton); 2014 Mar; 19(3):129-35. PubMed ID: 24397346
[TBL] [Abstract][Full Text] [Related]
19. NGAL is an early predictive biomarker of contrast-induced nephropathy in children.
Hirsch R; Dent C; Pfriem H; Allen J; Beekman RH; Ma Q; Dastrala S; Bennett M; Mitsnefes M; Devarajan P
Pediatr Nephrol; 2007 Dec; 22(12):2089-95. PubMed ID: 17874137
[TBL] [Abstract][Full Text] [Related]
20. Prevention of contrast-induced nephropathy with single bolus erythropoietin in patients with diabetic kidney disease: A randomized controlled trial.
Shema-Didi L; Kristal B; Eizenberg S; Marzuq N; Sussan M; Feldman-Idov Y; Ofir P; Atar S
Nephrology (Carlton); 2016 Apr; 21(4):295-300. PubMed ID: 26370061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
